Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Moxifloxacin Hydrochloride-Reference-Cited by-同舟云学术

Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Moxifloxacin Hydrochloride

Published:2020-09 Issue:9 Volume:109 Page:2654-2675
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Charoo Naseem A.,Abdallah Daud B.,Parveen Thahera,Abrahamsson Bertil,Cristofoletti Rodrigo,Groot Dirk W.,Langguth Peter,Parr Alan,Polli James E.,Mehta Mehul,Shah Vinod P.,Tajiri Tomokazu,Dressman Jennifer

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference148 articles.

1. Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy;Welte;Clin Infect Dis,2005

2. Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment;Finch;Antimicrobial Agents Chemother,2002

3. Community-acquired pneumonia recovery in the elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy;Anzueto;Clin Infect Dis,2006

4. 15-year experience of moxifloxacin in the treatment of patients with bacterial rhinosinusitis;Ovchinnikov;Vestn Otorinolaringol,2015

5. 10 years' experience with the pneumococcal quinolone moxifloxacin;Burkhardt;Expert Rev Anti Infect Ther,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and characterization of a copolymeric micelle containing soluble and insoluble model drugs;PLOS ONE;2023-05-25

2. Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Levocetirizine Dihydrochloride;Journal of Pharmaceutical Sciences;2023-04

3. A hybrid framework of artificial intelligence-based neural network model (ANN) and central composite design (CCD) in quality by design formulation development of orodispersible moxifloxacin tablets: Physicochemical evaluation, compaction analysis, and its in-silico PBPK modeling;Journal of Drug Delivery Science and Technology;2023-04

4. BCS Class II Drug & Its Solubility Enhancement: A Review;Journal for Research in Applied Sciences and Biotechnology;2022-12-07

5. An Assessment of Occasional Bio-Inequivalence for BCS1 and BCS3 Drugs: What are the Underlying Reasons?;Journal of Pharmaceutical Sciences;2022-01